Delivery Order SPE2DB20D3505-SPE2DB21FU4M0
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rizatriptan 10 mg oral disintegrating tablets in packs of 18. The total value of this award is $1,606.04, and it has an ultimate completion date of July 20, 2023. The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award, worth $2,418.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order, is for the supply of Rizatriptan 5 mg orally disintegrating tablets. It is a firm-fixed-price contract with a performance period through May 19, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,092.23 firm-fixed-price delivery order is for the supply of Rizatriptan 10 mg tablets to support military healthcare programs. The contract has an ultimate completion date of April 24, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,020.31 firm-fixed-price delivery order contract is for the supply of Rizatriptan 10 mg orally disintegrating tablets. The contract has an ultimate completion date of December 16, 2024 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of rizatriptan 5 mg orally disintegrating tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,505.84 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,867.38 firm fixed-price delivery order covers the supply of 4,563,750,623 units of Rizatriptan 10 mg tablets for an ultimate completion date of February 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,580.12 firm fixed-price delivery order covers the supply of 4557635156 units of Rizatriptan 10 mg Orally Disintegrating Tablets with a completion date of June 27, 2022. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,515.92, is a Firm Fixed Price Delivery Order for the supply of Rizatriptan 5 mg Tablet UD 18s. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Rizatriptan 5 mg orally disintegrating tablets. The firm fixed price Delivery Order, valued at $8,509.62, has a completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award, with ID SPE2DB22D1106|SPE2DB23FEHM1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,702.84 delivery order contract is for the supply of Rizatriptan 10 mg tablets to support defense healthcare programs. The contract is a firm fixed-price, non-set-aside award with a completion date of May 15, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB21FU4M0Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,407.84 firm fixed-price delivery order is for the supply of Rizatriptan 10 mg orally disintegrating tablets, with a completion date of September 16, 2021. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/15/21 |